Hartalega Holdings Berhad Valuation
Is HARTA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
[object Object] Score1/6
Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HARTA?
Other financial metrics that can be useful for relative valuation.
|What is HARTA's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does HARTA's PE Ratio compare to its peers?
|Company||PE||Estimated Growth||Market Cap|
TOPGLOV Top Glove Corporation Bhd
KOSSAN Kossan Rubber Industries Bhd
SUPERMX Supermax Corporation Berhad
COMFORT Comfort Gloves Berhad
HARTA Hartalega Holdings Berhad
Price-To-Earnings vs Peers: HARTA is expensive based on its Price-To-Earnings Ratio (32x) compared to the peer average (16.1x).
Price to Earnings Ratio vs Industry
How does HARTA's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
Price to Earnings Ratio vs Fair Ratio
What is HARTA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||32x|
|Fair PE Ratio||30x|
Price-To-Earnings vs Fair Ratio: HARTA is expensive based on its Price-To-Earnings Ratio (32x) compared to the estimated Fair Price-To-Earnings Ratio (30x).
Share Price vs Fair Value
What is the Fair Price of HARTA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HARTA (MYR1.66) is trading below our estimate of fair value (MYR1.89)
Significantly Below Fair Value: HARTA is trading below fair value, but not by a significant amount.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
|Date||Share Price||Average 1Y Price Target||Dispersion||High||Low||1Y Actual price||Analysts|
Analyst Forecast: Target price is less than 20% higher than the current share price.